Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II Registry(†)

AIMS: Current guidelines recommend implantable cardioverter-defibrillator (ICD) therapy for primary prevention of sudden cardiac death in patients with the reduced left ventricular function (LVEF ≤30%) not earlier than 40 days after myocardial infarction (MI). The aim of the prospective Prevention o...

Descripción completa

Detalles Bibliográficos
Autores principales: Völler, Heinz, Kamke, Wolfram, Klein, Helmut U., Block, Michael, Reibis, Rona, Treusch, Sven, Contzen, Klaus, Wegscheider, Karl
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065916/
https://www.ncbi.nlm.nih.gov/pubmed/21123220
http://dx.doi.org/10.1093/europace/euq426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065916/
https://www.ncbi.nlm.nih.gov/pubmed/21123220
http://dx.doi.org/10.1093/europace/euq426

Ejemplares similares